https://scholars.lib.ntu.edu.tw/handle/123456789/620234
標題: | Phase IA/IB study of single-agent tislelizumab, an investigational anti-PD-1 antibody, in solid tumors | 作者: | Desai J. Deva S. Lee J.S. CHIA-CHI LIN Yen C.-J. Chao Y. Keam B. Jameson M. Hou M.-M. Kang Y.-K. Markman B. Lu C.-H. Rau K.-M. Lee K.-H. Horvath L. Friedlander M. Hill A. Sandhu S. Barlow P. Wu C.-Y. Zhang Y. Liang L. Wu J. Paton V. Millward M. |
公開日期: | 2020 | 出版社: | BMJ Publishing Group | 卷: | 8 | 期: | 1 | 起(迄)頁: | e000453 | 來源出版物: | Journal for ImmunoTherapy of Cancer | URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85086620449&doi=10.1136%2fjitc-2019-000453&partnerID=40&md5=2272cfbc220c6672d5809a5f9aa14d3b https://scholars.lib.ntu.edu.tw/handle/123456789/620234 |
ISSN: | 2051-1426 | DOI: | 10.1136/jitc-2019-000453 |
顯示於: | 臨床醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。